No Data
No Data
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Sana Biotechnology Analyst Ratings
JMP Securities Maintains Sana Biotechnology(SANA.US) With Hold Rating
TD Cowen Maintains Sana Biotechnology(SANA.US) With Hold Rating
Sana Biotechnology: Hold Rating Amid Fiscal Caution and Strategic Priorities
No Data
No Data